Stephen Taub IPO Hopes Rise for Biopharma Investors Venture capital firms Bios Partners and Kairos Ventures own big stakes in Actuate Therapeutics, which has set the terms for its upcoming IPO. Stephen Taub June 17, 2024 Illustration by II